» Authors » Jeremy Heaton

Jeremy Heaton

Explore the profile of Jeremy Heaton including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 12
Citations 170
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
DeGroot J, Brundage M, Lam M, Rohland S, Heaton J, Mackillop W, et al.
Can Urol Assoc J . 2013 Jun; 7(5-6):E299-305. PMID: 23766831
Objective: We compared the cause-specific survival of patients who received radiotherapy to those who received surgery for cure of their prostate cancer using a number of design and analytic steps...
2.
Groome P, Rohland S, Siemens D, Brundage M, Heaton J, Mackillop W
Cancer . 2011 Aug; 117(17):3943-52. PMID: 21858801
Background: Treatment choice in prostate cancer is influenced by pre-existing comorbid illnesses, but information about their individual prognostic impact is sparse, and only 1 comorbidity index has been developed for...
3.
Fishbane S, Delmez J, Suki W, Hariachar S, Heaton J, Chasan-Taber S, et al.
Am J Kidney Dis . 2010 Jan; 55(2):307-15. PMID: 20042256
Background: Sevelamer carbonate powder for oral suspension is a new dosage form of sevelamer, which may be suited to once-daily dosing. Study Design: Randomized parallel open-label study. Setting & Participants:...
4.
Fan S, Ross C, Mitra S, Kalra P, Heaton J, Hunter J, et al.
Nephrol Dial Transplant . 2009 Aug; 24(12):3794-9. PMID: 19666658
Background: Sevelamer carbonate is an improved, buffered form of sevelamer hydrochloride developed for the treatment of hyperphosphataemia in CKD patients. Sevelamer carbonate formulated as a powder for oral suspension presents...
5.
Ketteler M, Rix M, Fan S, Pritchard N, Oestergaard O, Chasan-Taber S, et al.
Clin J Am Soc Nephrol . 2008 May; 3(4):1125-30. PMID: 18450923
Background And Objectives: Sevelamer carbonate is an improved, buffered form of sevelamer hydrochloride developed for the treatment of hyperphosphatemia in patients with chronic kidney disease. This study investigated the ability...
6.
de Tejada I, Angulo J, Cellek S, Gonzalez-Cadavid N, Heaton J, Pickard R, et al.
J Sex Med . 2006 Jan; 1(3):254-65. PMID: 16422955
Introduction: There are numerous investigations concerning the balance and interactions between relaxant and contractile factors regulating penile smooth muscle (arterial and trabecular) tone, the determinant of penile flaccidity or erection....
7.
de Tejada I, Angulo J, Cellek S, Gonzalez-Cadavid N, Heaton J, Pickard R, et al.
J Sex Med . 2006 Jan; 2(1):26-39. PMID: 16422902
Introduction: Multiple regulatory systems are involved in normal erectile function. Disruption of psychological, neurological, hormonal, vascular, and cavernosal factors, individually, or in combination, can induced erectile dysfunction (ED). The contribution...
8.
Althof S, Dean J, Fitzpatrick J, Heaton J, Rosen R
BJU Int . 2005 Nov; 96(9):1210-2. PMID: 16287429
No abstract available.
9.
Dean J, Eardley I, Hackett G, Heaton J, Kirby R
BJU Int . 2005 Jul; 96(3):234-6. PMID: 16042708
No abstract available.
10.
Montorsi F, Perani D, Anchisi D, Salonia A, Scifo P, Rigiroli P, et al.
Eur Urol . 2003 Apr; 43(4):405-11. PMID: 12667722
Objectives: To evaluate the in vivo effect of apomorphine sublingual versus placebo on cortical and subcortical brain activation during video sexual stimulation. Methods: Ten patients with psychogenic erectile dysfunction and...